Literature DB >> 26062841

Adjuvant Therapy With Sodium Alendronate for the Treatment of Experimental Periodontitis in Rats.

Juliano De Almeida1, Edilson Ervolino2, Luiz Henrique Bonfietti1, Vivian Cristina Noronha Novaes1, Letícia Helena Theodoro1, Leandro Araujo Fernandes3, Thiago Marchi Martins4, Paula Lazilha Faleiros1, Valdir Gouveia Garcia5.   

Abstract

BACKGROUND: This study assesses the effects of topical sodium alendronate (SA) as an adjuvant to the mechanical treatment of ligature-induced periodontitis in rats.
METHODS: Ninety animals were subjected to the induction of periodontitis via the installation of a ligature around the mandibular left first molar. After 7 days, the ligature was removed, and the animals were distributed into the following groups: 1) NT group (n = 30), no treatment; 2) SRP group (n = 30), scaling and root planing (SRP) and local irrigation with physiologic saline solution; and 3) SRP/SA group (n = 30), SRP and local irrigation with SA (10(-5) M). Ten animals from each group were euthanized at 7, 15, and 30 days after treatment. Histologic and histometric analyses were performed in the furcation region. The percentage of bone in the furcation (PBF) was measured. Immunohistochemical analyses for detecting the receptor activator of nuclear factor-κB ligand (RANKL), osteoprotegerin (OPG), tartrate-resistant acid phosphatase (TRAP), and activated caspase-3 were performed at the furcation region.
RESULTS: Compared with the other groups, the SRP/SA group showed less local inflammation and better tissue reparation during the entire experiment. There was more PBF in the SRP/SA group than in the other groups at days 7 and 15. Stronger OPG immunolabeling and weaker RANKL immunolabeling were observed in the SRP/SA group at 15 and 30 days. There were fewer TRAP-positive cells in the SRP/SA group than in the NT group at all of the time points. There was no difference in the number of activated caspase-3-positive osteocytes among groups and time points.
CONCLUSION: It can be concluded that topical use of SA as an adjuvant to SRP is effective in the treatment of experimental periodontitis.

Entities:  

Keywords:  Alendronate; periodontal diseases; periodontitis

Mesh:

Substances:

Year:  2015        PMID: 26062841     DOI: 10.1902/jop.2015.150166

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  13 in total

1.  Influence of systemic strontium ranelate on the progression and as adjunctive therapy for the nonsurgical treatment of experimental periodontitis.

Authors:  David-Jonathan-Rodrigues Gusman; Henrique-Rinaldi Matheus; Breno-Edson-Sendão Alves; Edilson Ervolino; Nathália-Januario de Araujo; Bianca-Rafaeli Piovezan; Luiz-Guilherme Fiorin; Juliano-Milanezi de Almeida
Journal:  J Clin Exp Dent       Date:  2021-12-01

2.  Influence of the treatment with the antineoplastic agents 5-fluorouracil and cisplatin on the severity of experimental periodontitis in rats.

Authors:  Vivian Cristina Noronha Novaes; Edilson Ervolino; Giovani Lopes Fernandes; Clara Possarle Cunha; Leticia Helena Theodoro; Valdir Gouveia Garcia; Juliano Milanezi de Almeida
Journal:  Support Care Cancer       Date:  2021-10-11       Impact factor: 3.603

3.  Effectiveness of alendronate as an adjunct to scaling and root planing in the treatment of periodontitis: a meta-analysis of randomized controlled clinical trials.

Authors:  Jin Chen; Qian Chen; Bo Hu; Yunji Wang; Jinlin Song
Journal:  J Periodontal Implant Sci       Date:  2016-12-26       Impact factor: 2.614

4.  Treatment of experimental periodontal disease by laser therapy in simvastatin-modified rats.

Authors:  Andressa Araújo Swerts; Bianca Fernanda Espósito Santos; Simone Ribeiro Bruzadelli; Maísa Ribeiro Pereira Lima Brigagão; Daniela Coelho de Lima; Leandro Araújo Fernandes
Journal:  J Appl Oral Sci       Date:  2017 Jul-Aug       Impact factor: 2.698

Review 5.  Biological Effects of Medicinal Plants on Induced Periodontitis: A Systematic Review.

Authors:  Jefferson Soares de Oliveira; Moara E Silva Conceição Pinto; Lucas de Araújo de Bastos Santana; Antonione Santos Bezerra Pinto; David di Lenardo; Daniel Fernando Pereira Vasconcelos
Journal:  Int J Dent       Date:  2016-09-21

6.  Local application of statins in the treatment of experimental periodontal disease in rats.

Authors:  Bianca Fernanda Espósito Santos; Eduardo Quintão Manhanini Souza; Maísa Ribeiro Pereira Lima Brigagão; Daniela Coelho de Lima; Leandro Araújo Fernandes
Journal:  J Appl Oral Sci       Date:  2017 Mar-Apr       Impact factor: 2.698

7.  Adjuvant therapy with 1% alendronate gel for experimental periodontitis treatment in rats.

Authors:  Natália de Campos Kajimoto; Yvonne de Paiva Buischi; Peter Michael Loomer; Timothy G Bromage; Edilson Ervolino; Stephen Enrico Fucini; Natália Marcumini Pola; Beatriz Ommati Pirovani; Maria Juliana Sismeiro Morábito; Juliano Milanezi de Almeida; Flávia Aparecida Chaves Furlaneto; Maria José Hitomi Nagata
Journal:  J Periodontal Implant Sci       Date:  2021-12       Impact factor: 2.614

8.  Evaluation of antimicrobial photodynamic therapy with acidic methylene blue for the treatment of experimental periodontitis.

Authors:  Juliano Milanezi de Almeida; Henrique Rinaldi Matheus; Breno Edson Sendão Alves; David Jonathan Rodrigues Gusman; Maria José Hitomi Nagata; Elisa Mara de Abreu Furquim; Edilson Ervolino
Journal:  PLoS One       Date:  2022-02-10       Impact factor: 3.240

9.  Effect of 1% sodium alendronate in the non-surgical treatment of periodontal intraosseous defects: a 6-month clinical trial.

Authors:  Bernardo Carvalho Dutra; Alcione Maria Soares Dutra Oliveira; Peterson Antônio Dutra Oliveira; Flavio Ricardo Manzi; Sheila Cavalca Cortelli; Luís Otávio de Miranda Cota; Fernando Oliveira Costa
Journal:  J Appl Oral Sci       Date:  2017 May-Jun       Impact factor: 2.698

10.  Role of 1% alendronate gel as adjunct to mechanical therapy in the treatment of chronic periodontitis among smokers.

Authors:  Anuj Sharma; Achala Raman; Avani Raju Pradeep
Journal:  J Appl Oral Sci       Date:  2017 May-Jun       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.